Da An Gene Co Ltd of Sun Yat-Sen University
Daan Gene Co., Ltd., together with its subsidiaries, researches and develops, manufactures, and sells clinical test reagents, instruments, and supporting consumables in China. It operates through two segments, Biological Products and Related Business and Financial Business. The company offers reagents for hepatitis virus, sexually transmitted infections, blood screening, digestive pathogens, coro… Read more
Da An Gene Co Ltd of Sun Yat-Sen University (002030) - Total Assets
Latest total assets as of September 2025: CN¥9.09 Billion CNY
Based on the latest financial reports, Da An Gene Co Ltd of Sun Yat-Sen University (002030) holds total assets worth CN¥9.09 Billion CNY as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Da An Gene Co Ltd of Sun Yat-Sen University - Total Assets Trend (2001–2024)
This chart illustrates how Da An Gene Co Ltd of Sun Yat-Sen University’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Da An Gene Co Ltd of Sun Yat-Sen University - Asset Composition Analysis
Current Asset Composition (December 2024)
Da An Gene Co Ltd of Sun Yat-Sen University's total assets of CN¥9.09 Billion consist of 39.5% current assets and 60.5% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 9.1% |
| Accounts Receivable | CN¥1.30 Billion | 13.5% |
| Inventory | CN¥198.21 Million | 2.1% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥919.62 Million | 9.6% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2001–2024)
This chart illustrates how Da An Gene Co Ltd of Sun Yat-Sen University's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Da An Gene Co Ltd of Sun Yat-Sen University's current assets represent 39.5% of total assets in 2024, a decrease from 41.9% in 2001.
- Cash Position: Cash and equivalents constituted 9.1% of total assets in 2024, down from 22.4% in 2001.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 9.0% of total assets, an increase from 0.0% in 2001.
- Asset Diversification: The largest asset category is accounts receivable at 13.5% of total assets.
Da An Gene Co Ltd of Sun Yat-Sen University Competitors by Total Assets
Key competitors of Da An Gene Co Ltd of Sun Yat-Sen University based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Da An Gene Co Ltd of Sun Yat-Sen University - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Da An Gene Co Ltd of Sun Yat-Sen University generates 0.09x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Da An Gene Co Ltd of Sun Yat-Sen University is currently not profitable relative to its asset base.
Da An Gene Co Ltd of Sun Yat-Sen University - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.06 | 4.10 | 2.10 |
| Quick Ratio | 2.85 | 3.90 | 1.94 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥1.93 Billion | CN¥ 3.81 Billion | CN¥ 2.26 Billion |
Da An Gene Co Ltd of Sun Yat-Sen University - Advanced Valuation Insights
This section examines the relationship between Da An Gene Co Ltd of Sun Yat-Sen University's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.14 |
| Latest Market Cap to Assets Ratio | 0.08 |
| Asset Growth Rate (YoY) | -13.1% |
| Total Assets | CN¥9.58 Billion |
| Market Capitalization | $784.18 Million USD |
Valuation Analysis
Below Book Valuation: The market values Da An Gene Co Ltd of Sun Yat-Sen University's assets below their book value (0.08 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Da An Gene Co Ltd of Sun Yat-Sen University's assets decreased by 13.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Da An Gene Co Ltd of Sun Yat-Sen University (2001–2024)
The table below shows the annual total assets of Da An Gene Co Ltd of Sun Yat-Sen University from 2001 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥9.58 Billion | -13.08% |
| 2023-12-31 | CN¥11.02 Billion | -25.34% |
| 2022-12-31 | CN¥14.76 Billion | +42.77% |
| 2021-12-31 | CN¥10.34 Billion | +54.27% |
| 2020-12-31 | CN¥6.70 Billion | +88.12% |
| 2019-12-31 | CN¥3.56 Billion | -2.78% |
| 2018-12-31 | CN¥3.66 Billion | -21.08% |
| 2017-12-31 | CN¥4.64 Billion | +12.13% |
| 2016-12-31 | CN¥4.14 Billion | +36.10% |
| 2015-12-31 | CN¥3.04 Billion | +91.28% |
| 2014-12-31 | CN¥1.59 Billion | +37.66% |
| 2013-12-31 | CN¥1.16 Billion | +26.63% |
| 2012-12-31 | CN¥912.28 Million | +16.17% |
| 2011-12-31 | CN¥785.29 Million | +16.55% |
| 2010-12-31 | CN¥673.75 Million | +15.14% |
| 2009-12-31 | CN¥585.17 Million | +10.43% |
| 2008-12-31 | CN¥529.90 Million | +24.43% |
| 2007-12-31 | CN¥425.87 Million | +30.60% |
| 2006-12-31 | CN¥326.08 Million | +9.85% |
| 2005-12-31 | CN¥296.85 Million | -5.15% |
| 2004-12-31 | CN¥312.97 Million | +77.39% |
| 2003-12-31 | CN¥176.43 Million | +35.15% |
| 2002-12-31 | CN¥130.54 Million | +30.92% |
| 2001-12-31 | CN¥99.71 Million | -- |